Article info
PDFClinical science
Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
- Correspondence to Professor Jean-François Rouland, Service ophtalmologie, CHRU de Lille, Place de Verdun, Lille 59000, France; jfr3{at}wanadoo.fr
Citation
Efficacy and safety of preservative-free latanoprost eyedrops, compared with BAK-preserved latanoprost in patients with ocular hypertension or glaucoma
Publication history
- Received May 30, 2012
- Revised October 3, 2012
- Accepted November 5, 2012
- First published November 30, 2012.
Online issue publication
October 19, 2022
Article Versions
- Previous version (19 October 2022).
- Previous version (19 October 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions